Combination of NEP 1-40 infusion and bone marrow-derived neurospheres transplantation inhibit glial scar formation and promote functional recovery after rat spinal cord injury

Neurology India

Volumn 59, Issue 4, 2011, Pages 579-585

  Zhou, Zhilai ^a   Hui, Zhang ^a   Chen, Yinhai ^a   Chen, Zhong ^a   Min, Shaoxiong ^a   Bo, Yu ^a   Jin, Anmin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow stromal cell; NEP1 40; neurosphere; Nogo A; spinal cord injury

Indexed keywords

NEP1-40; NOGO 66 RECEPTOR; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FLUORESCENCE MICROSCOPE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; LOCOMOTION; MUSCULOSKELETAL FUNCTION; NONHUMAN; RAT; SCAR FORMATION; SPINAL CORD INJURY; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; BROMODEOXYURIDINE; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CICATRIX; DISEASE MODELS, ANIMAL; INJECTIONS, SPINAL; LOCOMOTION; MYELIN PROTEINS; NERVE TISSUE PROTEINS; NEUROGLIA; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 80053430072     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.84341     Document Type: Article

References (25)

1. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000;403:434-9. (Pubitemid 30073093)
2. Goldberg JL, Barres BA. Nogo in nerve regeneration. Nature 2000;403:369-70. (Pubitemid 30073065)
3. Buchli AD, Schwab ME. Inhibition of Nogo: A key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann Med 2005;37:556-67. (Pubitemid 41780144)
4. GrandPre T, Li S, Strittmatter SM. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002;417:547-51. (Pubitemid 34595921)
5. Fang PC, Barbay S, Plautz EJ, Hoover E, Strittmatter SM, Nudo RJ. Combination of NEP 1-40 treatment and motor training enhances behavioral recovery after a focal cortical infarct in rats. Stroke 2010;41:544-9.
6. Li S, Strittmatter SM. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci 2003;23:4219-27. (Pubitemid 36958442)
7. Mingorance A, Sole M, Muneton V, Martinez A, Nieto-Sampedro M, Soriano E, et al. Regeneration of lesioned entorhino-hippocampal axons in vitro by combined degradation of inhibitory proteoglycans and blockade of Nogo-66/NgR signaling. FASEB J 2006;20:491-3. (Pubitemid 46671226)
8. Cao Y, Shumsky JS, Sabol MA, Kushner RA, Strittmatter S, Hamers FP, et al. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat. Neurorehabil Neural Repair 2008;22:262-78. (Pubitemid 351561674)
9. Sahni V, Kessler JA. Stem cell therapies for spinal cord injury. Nat Rev Neurol 2010;6:363-72.
10. Kamei N, Tanaka N, Oishi Y, Hamasaki T, Nakanishi K, Sakai N, et al. BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic cocultures. Spine (Phila Pa 1976) 2007;32:1272-8. (Pubitemid 46791444)
11. Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 2003;181: 115-29. (Pubitemid 36629234)
12. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 2001;19:180-92. (Pubitemid 32524539)
13. Yang Q, Mu J, Li Q, Li A, Zeng Z, Yang J, et al. A simple and efficient method for deriving neurospheres from bone marrow stromal cells. Biochem Biophys Res Commun 2008;372:520-4.
14. Zhang HT, Cheng HY, Cai YQ, Ma X, Liu WP, Yan ZJ, et al. Comparison of adult neurospheres derived from different origins for treatment of rat spinal cord injury. Neurosci Lett 2009;458:116-21.
15. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, et al. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 2003;89: 1235-49. (Pubitemid 36959389)
16. Cho SR, Kim YR, Kang HS, Yim SH, Park CI, Min YH, et al. Functional recovery after the transplantation of neurally differentiated mesenchymal stem cells derived from bone barrow in a rat model of spinal cord injury. Cell Transplant 2009;18:1359-68.
17. Zhang L, Zhang HT, Hong SQ, Ma X, Jiang XD, Xu RX. Cografted Wharton's jelly cells-derived neurospheres and BDNF promote functional recovery after rat spinal cord transection. Neurochem Res 2009;34:2030-9.
18. Hains BC, Saab CY, Lo AC, Waxman SG. Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI. Exp Neurol 2004;188:365-77. (Pubitemid 38891597)
19. Hofstetter CP, Holmstrom NA, Lilja JA, Schweinhardt P, Hao J, Spenger C, et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 2005;8:346-53. (Pubitemid 40300192)
20. Wang B, Xiao Z, Chen B, Han J, Gao Y, Zhang J, et al. Nogo-66 promotes the differentiation of neural progenitors into astroglial lineage cells through mTOR-STAT3 pathway. PLoS One 2008;3:e1856.
21. Lu P, Jones LL, Tuszynski MH. Axon regeneration through scars and into sites of chronic spinal cord injury. Exp Neurol 2007;203: 8-21. (Pubitemid 44821162)
22. Wang X, Chun SJ, Treloar H, Vartanian T, Greer CA, Strittmatter SM. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axonmyelin and synaptic contact. J Neurosci 2002;22:5505-15. (Pubitemid 35386472)
23. Hasegawa Y, Yamagishi S, Fujitani M, Yamashita T. p75 neurotrophin receptor signaling in the nervous system. Biotechnol Annu Rev 2004;10:123-49. (Pubitemid 39419991)
24. MacDermid VE, McPhail LT, Tsang B, Rosenthal A, Davies A, Ramer MS. A soluble Nogo receptor differentially affects plasticity of spinally projecting axons. Eur J Neurosci 2004;20:2567-79. (Pubitemid 39573772)
25. Gou X, Wang Q, Yang Q, Xu L, Xiong L. TAT-NEP1-40 as a novel therapeutic candidate for axonal regeneration and functional recovery after stroke. J Drug Target 2011;19:86-95.